Core Insights - The Chinese AI + medical imaging industry is rapidly developing, with a market size projected to reach 7.6 billion yuan in 2024, representing a year-on-year growth of 109.94% [1][11] - AI technology is capable of quickly identifying small lesions from vast amounts of imaging data, facilitating precise early screening for various diseases and providing significant diagnostic support for doctors [1][11] - The product types in AI medical imaging are diversifying, with a trend towards integrated hardware and software solutions becoming the preferred choice for medical institutions [1][11] Industry Overview - AI + medical imaging refers to the use of AI technologies, such as deep learning and computer vision, to analyze and process medical images (e.g., X-rays, CT scans, MRIs, ultrasounds) to assist doctors in disease diagnosis, treatment planning, and prognosis evaluation [1][4] - The core function includes auxiliary diagnosis, treatment planning, prognosis assessment, and early detection screening [1][4] Industry Value Chain - The upstream of the AI + medical imaging industry includes medical imaging equipment, chips, servers, storage devices, imaging acquisition and processing software, cloud services, network operation platforms, and algorithm and data platforms [4] - The midstream involves the development and manufacturing of AI + medical imaging technologies, while the downstream primarily serves medical institutions, health check centers, and research and educational institutions [4] Market Size - The market size of the Chinese medical imaging equipment industry is expected to reach 69.3 billion yuan in 2024, with a year-on-year growth of 9.83% [6] Relevant Policies - The Chinese government has issued several policy documents to support and regulate the development of the AI + medical imaging industry, emphasizing the optimization of medical device standards and the establishment of standardization organizations for AI and medical robotics [8][10] - The policies aim to accelerate approval processes, enhance innovation ecosystems, and improve international competitiveness [8][10] Key Companies and Performance - Major companies in the AI + medical imaging sector include United Imaging Healthcare, Wandong Medical, Mindray, and Shukun Technology, each leveraging unique strengths in hardware and AI software integration [13][15] - United Imaging Healthcare reported a revenue of 10.3 billion yuan in 2024, a decrease of 9.73% year-on-year, while its R&D investment increased by 17.84% to 2.261 billion yuan [15] - Shukun Technology focuses on providing comprehensive AI solutions for medical institutions, achieving significant market penetration with its innovative products [17] Industry Development Trends 1. The industry is expected to advance towards multi-modal data integration and deep learning, enhancing diagnostic accuracy and personalized treatment [20] 2. Applications of AI in medical imaging will expand from auxiliary diagnosis to full-process management, improving service efficiency and quality [21] 3. Regulatory frameworks will evolve to include data privacy protections and accountability mechanisms for AI-generated content [22]

Core Viewpoint - The article discusses the transformation of artificial intelligence (AI) from a laboratory demonstration to a practical tool in society, highlighting the upcoming 2025 World Artificial Intelligence Conference (WAIC) in Shanghai, which will focus on the future of AI and its applications [1]. Group 1: WAIC 2025 Overview - The WAIC 2025 will take place from July 26 to 28 in Shanghai, featuring over 1,200 leaders from more than 30 countries, including 12 international award winners and over 80 academicians [1]. - The theme of the conference is "Intelligent Era, Shared Future," aiming to explore cutting-edge technologies, industry trends, and governance in the AI field [1]. Group 2: AI Partner Live Broadcast - 36Kr will collaborate with the WAIC organizing committee to launch the "AI Partner Live Broadcast," which will include discussions with industry leaders and explorations of cutting-edge technologies [2]. - The live broadcast will feature new segments such as "WAIC Live Exhibition" and "36Kr Interview Room," presenting AI companies' technological breakthroughs and real-world applications [2]. Group 3: Key Discussions and Topics - The live discussions will cover various topics, including the challenges and strategies for AI applications going global, particularly focusing on overcoming computational bottlenecks [6][7]. - Another discussion will address the innovative practices of AI Agents in the medical payment sector, exploring how AI can solve long-standing industry challenges [8][9]. - The impact of AI on personal computing and human-machine collaboration will also be a focal point, analyzing how AI can enhance user experience and operational efficiency [10][11]. Group 4: Industry Insights and Innovations - The conference will delve into the necessary conditions for AI companies to transition from research and development to mass production, including the role of investment funds and supportive ecosystems [14]. - Discussions will also explore the breakthroughs in AI medical imaging and the new paradigms for industry development, emphasizing the transformative effects of AI on healthcare [15][16]. Group 5: Live Exhibition Highlights - The WAIC live exhibition will feature immersive experiences showcasing AI applications across various sectors, including smart offices, robotics, and intelligent factories [18]. - Attendees will learn about the advantages of specific regions, such as the Dongguan Binhai Bay New Area, and how local funds are supporting AI development [19]. - The exhibition will also highlight practical AI tools for office productivity, demonstrating how AI can significantly reduce time spent on tasks like report writing and presentation creation [19].

Core Insights - The aging population, scarcity of grassroots medical resources, and uneven distribution of quality medical resources are driving the rapid integration and application of AI technology in the healthcare sector [2] - AI medical technology is expected to reconstruct the medical value chain, creating a new model for equitable access to medical resources [5] - The domestic AI medical market is projected to reach 159.8 billion yuan by 2028, with a compound annual growth rate of 10.5% from 2022 to 2028 [7] Industry Overview - The aging population in China is expected to reach 310 million by the end of 2024, accounting for 22% of the total population, and is projected to exceed 400 million by 2035, surpassing 30% [2] - Grassroots medical institutions account for 94.9% of all medical institutions in China but only handle 51.8% of the total medical services, indicating a mismatch in resource utilization and service quality [2] - AI technology is being rapidly integrated across various medical processes, including imaging diagnosis, surgical assistance, drug development, and intelligent management [2] AI Medical Technology - AI medical technology enhances the quality and efficiency of healthcare services by providing intelligent management and optimization of medical processes [3] - AI medical devices can be categorized into two types: those that include hardware (e.g., diagnostic analysis systems, robots) and those that operate as standalone software [3] - The advantages of AI in healthcare include high efficiency, accuracy, and low misdiagnosis rates, which can significantly improve diagnostic processes and treatment timelines [4] Market Potential - The AI medical market is expanding rapidly, with significant applications in drug and vaccine development, medical imaging analysis, smart hospital management, and genomics research [7] - AI applications in in-vitro diagnostics are expected to grow at a compound annual growth rate of 26.1% by 2028 [17] Company Profiles - Mindray Medical (300760) has a comprehensive product line in life information and support, in vitro diagnostics, and medical imaging, with a projected revenue of 36.725 billion yuan in 2024, a 5.14% increase year-on-year [10] - United Imaging (688271) focuses on medical imaging equipment and has been investing in AI since 2017, with a projected revenue of 10.3 billion yuan in 2024, a 9.73% decrease year-on-year [14] - BGI Genomics (300676) specializes in genomic testing services and is expected to generate 3.867 billion yuan in revenue in 2024, an 11.10% decrease year-on-year [19] - Yuyue Medical (002223) is a leading provider of medical devices, with a projected revenue of 7.566 billion yuan in 2024, a 5.09% decrease year-on-year [23] - Kefu Medical (301087) focuses on home medical devices and is expected to achieve 2.983 billion yuan in revenue in 2024, a 4.53% increase year-on-year [25]

AI医疗器械爆发前夜：医学影像与诊断设备引领千亿级市场变革 头豹词条报告系列 2025-02-28 未经平台授权，禁止转载 摘要 AI医疗器械行业基于医疗器械数据，采用人工智能技术实现医疗用途。国家药监局颁布相关指导原则，规范行业生存周期过程。行业应用领域广泛，入局企业多样化，三类 证获批数量稳定增加。市场规模逐年扩大，得益于人工智能技术商业化落地、政策导向驱动及AI医疗器械逐步渗透至医疗机构及第三方影像中心。未来，随着更多领域产品 的获批上市及企业研发技术的深入，市场竞争将加剧，AI医疗器械行业市场前景广阔。 行业定义 人工智能医疗器械是指基于"医疗器械数据"，采用人工智能技术实现其预期用途（即医疗用途）的医疗器械。而医疗器械数据是指医疗器械 产生的用于医疗用途的客观数据，如医学影像设备产生的医学图像数据、医用电子设备产生的生理参数数据等。 2022年3月，国家药监局颁布《人工智能医疗器械注册审查指导原则》，对人工智能医疗器械类型进行界定，并对人工智能医疗器械生存周 期过程，包括需求分析、数据收集、算法设计、验证确认、更新控制等环节做出了规定，并提供了16类技术考量因素。 行业分类 AI医疗器械的分类方式多 ...